Abstract:Zichen Wang, 1– 3, &ast Wen Wang, 1– 3, &ast Mingqi Wang, 1– 3 Qiao He, 1– 3 Jiayue Xu, 1– 3 Kang Zou, 1– 3 Yan Kang, 4 Xin Sun 1– 3 1 Institute of Integrated Traditional Chinese and Western Medicine, Chinese Evidence-Based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 2 NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, 610041, People's Republic of China; 3 Sichuan Center of Technology Innovation for Real World Data, Chengdu, People's Republic of China; 4 Intensive Care Unit, West China Hospital of Sichuan University, Chengdu, 610041, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Kang; Xin Sun, Email ; Objective: To identify subclasses of acute pancreatitis (AP) patients in the intensive care unit (ICU) by analyzing blood urea nitrogen (BUN) trajectories. Methods: AP patients in West China Hospital System (development cohort) and three public databases in the United States (validation cohort) were included. Latent class trajectory modelling was used to identify subclasses based on BUN trajectories within the first 21 days after ICU admission. Clinical characteristics and outcomes were compared, and results were externally validated. Results: The study comprised 2971 and 930 patients in the development and validation cohorts, respectively, with five subclasses: Class 1 ("Moderate-azotemia, slow decreasing"), Class 2 ("Non-azotemia"), Class 3 ("Severe-azotemia, slow decreasing"), Class 4 ("Moderate-azotemia, rapid increasing"), and Class 5 ('Moderate-azotemia, slow increasing) identified. Azotemia patients showed significantly higher 30-day mortality risk in development and validation cohorts. Specifically, Class 4 patients exhibited notably highest mortality risk in both the development cohort (HR 5.32, 95% CI 2.62– 10.82) and validation cohort (HR 6.23, 95% CI 2.93– 13.22). Regarding clinical characteristics, AP patients in Class 4 showed lower mean arterial pressure and a higher proportion of renal disease. We also created an online early classification model to further identify Class 4 patients among all patients with moderate azotemia at baseline. Conclusion: This multinational study uncovers heterogeneity in BUN trajectories among AP patients. Patients with "Moderate-azotemia, rapid increasing" trajectory, had a higher mortality risk than patients with severe azotemia at baseline. This finding complements studies that solely rely on baseline BUN for risk stratification and enhanced our understanding of longitudinal progression of AP. Keywords: acute pancreatitis, BUN, trajectories analysis, ICU Acute pancreatitis (AP) is an inflammatory condition commonly caused by bile stones or excessive dose of alcohol and is one of the most prevalent gastrointestinal diseases that needs hospitalization. 1–3 About 20–40% of AP patients will develop into severe AP (SAP) with persistent organ failure that requires intensive care unit (ICU) admission and had about 30% risk of mortality. 4–7 The blood urea nitrogen (BUN) level can provide valuable insights into the physiological condition in AP, including intravascular volume depletion, prerenal azotemia, kidney injury, potential gastrointestinal bleeding, and the response to fluid resuscitation. 8–10 Therefore, monitoring BUN levels can guide clinicians in taking appropriate interventions to manage AP patients effectively, and BUN has been identified as an important prognostic factor for AP. Previous studies suggested that as a dynamic biomarker, both baseline and early trends of BUN change were significantly associated with mortality in AP patients. 9–11 Wu et al found that the odds ratio (OR)s of in-hospital mortality was 2.9 and 2.2 for every 5 mg/dL increment of admission/24-hour change in BUN in patients with AP. 10 In another study, the pooled ORs of mortality in patients with AP were 4.60 and 4.28 for elevated admission BUN (≥20 mg/dL) and any increment of BUN in the first 24 hours, respectively. 9 Good prognostic performance has also been demonstrated by both direct BUN levels and BUN-based prediction models for AP patients. 9,12 In the ICU, BUN is a repeatedly measured biomarker with dynamic developmental patterns, while studies to date have only analyzed the association between baseline/first 24-hour difference in BUN levels and AP mortality. To our knowledge, no study has analyzed BUN longitudinal data, although current evidence indicates that the dynamic change of BUN is essenti -Abstract Truncated-

Blood Urea Nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU

The association of blood urea nitrogen levels upon emergency admission with mortality in acute exacerbation of chronic obstructive pulmonary disease

Relationship between blood urea nitrogen-to-creatinine ratio at hospital admission and long-term mortality in patients with acute decompensated heart failure

Elevated BUN Upon Admission as a Predictor of in-Hospital Mortality Among Patients with Acute Exacerbation of COPD: A Secondary Analysis of Multicenter Cohort Study

Blood urea nitrogen variation upon admission and at discharge in patients with heart failure

Blood Urea Nitrogen to Left Ventricular Ejection Ratio as a Predictor of Short-Term Outcome in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Prediction of prognosis in patients with nontraumatic intracranial hemorrhage using blood urea nitrogen-to-creatinine ratio on admission: a retrospective cohort study based on data from the medical information Mart for intensive care-IV database

Relationship between blood urea nitrogen to serum albumin ratio and short-term mortality among patients from the surgical intensive care unit: a population-based real-world study

Association Between an Increase in Blood Urea Nitrogen at 24 H and Worse Outcomes in COVID-19 Pneumonia

Novel Prognostic Predictor for Primary Pulmonary Hypertension: Focus on Blood Urea Nitrogen

Association of Blood Urea Nitrogen with Cardiovascular Diseases and All-Cause Mortality in USA Adults: Results from NHANES 1999–2006

Prognostic impact of blood urea nitrogen to albumin ratio on patients with sepsis: a retrospective cohort study

Blood urea nitrogen to serum albumin ratio: a good predictor of in-hospital and 90-day all-cause mortality in patients with acute exacerbations of chronic obstructive pulmonary disease

Elevated Blood Urea Nitrogen-to-Serum Albumin Ratio as a Factor That Negatively Affects the Mortality of Patients with Hospital-Acquired Pneumonia

Blood Urine Nitrogen Trajectories of Acute Pancreatitis Patients in Intensive Care Units

Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure

Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction

Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure

Potential role and influencing parameters of serum urea nitrogen among hospitalized older adults

BUN/creatinine ratio associated with mortality in patients with cirrhosis and acute kidney injury.

The association of blood urea nitrogen-to-creatinine ratio and in-hospital mortality in acute ischemic stroke patients with atrial fibrillation: data from the MIMIC-IV database